Nuclear Medicine — Residency
Nuclear Medicine: 75 lectures in Residency (Residency). Atomic Structure and Radioactive Decay · Interaction of Radiation with Matter · Radiation Detection and Instrumentation · The Gamma Camera: Principles and Quality Control · SPECT Acquisition and Reconstruction · PET Physics and Instrumentation
- Atomic Structure and Radioactive Decay
- Interaction of Radiation with Matter
- Radiation Detection and Instrumentation
- The Gamma Camera: Principles and Quality Control
- SPECT Acquisition and Reconstruction
- PET Physics and Instrumentation
- PET/CT and SPECT/CT: Hybrid Imaging Principles
- Radiation Dosimetry and Internal Dose Calculation
- Radiation Biology for Nuclear Medicine
- Radiopharmaceutical Chemistry Essentials
- Tc-99m: Generator System and Kit Preparation
- F-18 FDG: Production, Biodistribution, and Pitfalls
- Non-FDG PET Radiopharmaceuticals
- Radiopharmaceutical Regulations and USP 825
- Myocardial Perfusion Imaging: Stress Protocols
- Myocardial Perfusion SPECT: Acquisition and Interpretation
- PET Myocardial Perfusion and Flow Quantification
- Cardiac Viability Assessment
- Cardiac Amyloidosis Scintigraphy
- MUGA Scan and Cardiac Function Assessment
- FDG PET/CT in Lung Cancer
- FDG PET/CT in Lymphoma
- FDG PET/CT in Head and Neck Cancer
- FDG PET/CT in Melanoma and Sarcoma
- FDG PET/CT in Gastrointestinal Malignancies
- PSMA PET/CT in Prostate Cancer
- PET/CT in Infection and Inflammation
- Tumor Response Assessment: RECIST, PERCIST, and Beyond
- Thyroid Scintigraphy: Tc-99m Pertechnetate and I-123
- Radioiodine Therapy for Hyperthyroidism
- Differentiated Thyroid Cancer: Post-Surgical I-131 Therapy
- Post-Therapy I-131 Whole Body Scan Interpretation
- Thyroid Cancer Surveillance: Thyroglobulin and Diagnostic I-131/I-123 Scans
- Ventilation-Perfusion (V/Q) Lung Scintigraphy
- Quantitative Lung Perfusion Scintigraphy
- Dynamic Renal Scintigraphy: Tc-99m MAG3 and Tc-99m DTPA
- Captopril Renography for Renovascular Hypertension
- Renal Cortical Scintigraphy: DMSA Scan
- Renal Transplant Evaluation with Nuclear Medicine
- Gastric Emptying Scintigraphy
- Gastrointestinal Bleeding Scintigraphy
- Meckel Diverticulum Scintigraphy
- Hepatobiliary Scintigraphy (HIDA Scan)
- Three-Phase Bone Scintigraphy
- Bone Scintigraphy for Metastatic Disease
- Bone SPECT/CT: Added Value and Clinical Applications
- Brain FDG PET in Dementia Evaluation
- Amyloid and Tau PET Imaging
- DaTscan: Dopamine Transporter Imaging
- Brain Perfusion SPECT: Ictal and Interictal Epilepsy Imaging
- CSF Flow Studies and Cisternography
- Theranostics: Concept and Clinical Framework
- Lu-177 DOTATATE Therapy for Neuroendocrine Tumors
- Lu-177 PSMA Therapy for Metastatic Prostate Cancer
- Radium-223 for Bone-Predominant Metastatic Prostate Cancer
- I-131 MIBG Therapy for Neuroblastoma and Pheochromocytoma
- Emerging Theranostic Targets and Agents
- Pediatric Dose Optimization and the Image Gently Campaign
- Pediatric Renal Scintigraphy: VUR and UTI Evaluation
- Pediatric Oncologic Nuclear Medicine
- NRC Regulatory Framework for Nuclear Medicine
- Occupational Radiation Safety and ALARA
- Patient Release Criteria After Radionuclide Therapy
- Medical Events and Misadministrations
- Radioactive Waste Management and Transportation
- Sentinel Lymph Node Mapping
- Ga-68 DOTATATE PET/CT for Neuroendocrine Tumors
- Parathyroid Scintigraphy
- Adrenal Imaging: MIBG and NP-59
- Salivary Gland Scintigraphy
- Lymphoscintigraphy for Lymphedema
- PET/MRI: Principles and Clinical Applications
- Artificial Intelligence and Quantitative Nuclear Medicine
- Total-Body PET: Ultra-High Sensitivity Imaging
- Y-90 Radioembolization for Hepatic Malignancies